Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Brandjes

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|April 8, 1998
The clinical course of patients with suspected pulmonary embolismE J van Beek, P M Kuijer, H R Büller, et al.
Clinical Chemistry|July 1, 1985
Urinary creatine: biochemical indicator for evaluation of sickle cell crisesC Beyer, L W Statius van Eps, J J Kastelein, et al.
Chest|July 1, 1995
A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validityE J van Beek, P M Kuyer, B E Schenk, et al.
Thrombosis and Haemostasis|July 15, 2000
Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study GroupM R Mac Gillavry, W de Monyé, J G Lijmer, et al.
Lancet (London, England)|February 2, 1991
Mortality in hereditary antithrombin-III deficiency--1830 to 1989F R Rosendaal, H Heijboer, E Briët, et al.
The Journal of Infectious Diseases|June 3, 1999
Review: infectious diseases and coagulation disordersE C van Gorp, C Suharti, H ten Cate, et al.
Thrombosis and Haemostasis|October 6, 2000
Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study GroupM R Mac Gillavry, B J Sanson, W de Monyé, et al.
British Journal of Haematology|May 1, 2001
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic feverE C van Gorp, M C Minnema, C Suharti, et al.
British Journal of Haematology|July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?H J Wolters, H ten Cate, L L Thomas, et al.
Thrombosis and Haemostasis|September 1, 1993
A comparative analysis of D-dimer assays in patients with clinically suspected pulmonary embolismE J van Beek, B van den Ende, R J Berckmans, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|April 8, 1998
The clinical course of patients with suspected pulmonary embolismE J van Beek, P M Kuijer, H R Büller, et al.
Clinical Chemistry|July 1, 1985
Urinary creatine: biochemical indicator for evaluation of sickle cell crisesC Beyer, L W Statius van Eps, J J Kastelein, et al.
Chest|July 1, 1995
A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validityE J van Beek, P M Kuyer, B E Schenk, et al.
Thrombosis and Haemostasis|July 15, 2000
Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study GroupM R Mac Gillavry, W de Monyé, J G Lijmer, et al.
Lancet (London, England)|February 2, 1991
Mortality in hereditary antithrombin-III deficiency--1830 to 1989F R Rosendaal, H Heijboer, E Briët, et al.
The Journal of Infectious Diseases|June 3, 1999
Review: infectious diseases and coagulation disordersE C van Gorp, C Suharti, H ten Cate, et al.
Thrombosis and Haemostasis|October 6, 2000
Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study GroupM R Mac Gillavry, B J Sanson, W de Monyé, et al.
British Journal of Haematology|May 1, 2001
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic feverE C van Gorp, M C Minnema, C Suharti, et al.
British Journal of Haematology|July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?H J Wolters, H ten Cate, L L Thomas, et al.
Thrombosis and Haemostasis|September 1, 1993
A comparative analysis of D-dimer assays in patients with clinically suspected pulmonary embolismE J van Beek, B van den Ende, R J Berckmans, et al.
Pageof 4